Trials / Conditions / SLL (Small Lymphocytic Lymphoma)
SLL (Small Lymphocytic Lymphoma)
4 registered clinical trials studyying SLL (Small Lymphocytic Lymphoma) — 3 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Not Yet Recruiting | A Phase Ib Study of the Selective PKC-β Inhibitor MS-553 in Patients With Refractory or Relapsed CLL/SLL NCT06979076 | MingSight Pharmaceuticals, Inc | Phase 1 / Phase 2 |
| Not Yet Recruiting | ROCKET-CLL Global Phase 3 Study: Rocbrutinib vs Pirtobrutinib in cBTKi-Pretreated R/R CLL/SLL NCT07342478 | Newave Pharmaceutical Inc | Phase 3 |
| Recruiting | A Phase 1 Study of ZE50-0134 in Relapsed and Refractory Chronic Lymphocytic Leukemia, Small Lymphocytic Lympho NCT06708897 | Lomond Therapeutics Holdings, Inc. | Phase 1 |
| Active Not Recruiting | PCI-32765 for Special Cases of Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma NCT01500733 | National Heart, Lung, and Blood Institute (NHLBI) | Phase 2 |